Neurogene Inc. (NGNE)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
NGNE Insider Trading Activity
NGNE Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $2,720,023 | 3 | 75 |
Sells | $76,247 | 1 | 25 |
Related Transactions
| Samsara BioCapital GP, LLC | 10 percent owner | 1 | $1.26M | 0 | $0 | $1.26M |
| McMinn Rachel | Chief Executive Officer | 1 | $969,000 | 0 | $0 | $969,000 |
| Cvijic Christine Mikail | President and CFO | 1 | $491,400 | 1 | $76,247 | $415,153 |
About Neurogene Inc.
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Insider Activity of Neurogene Inc.
Over the last 12 months, insiders at Neurogene Inc. have bought $2.72M and sold $76,247 worth of Neurogene Inc. stock.
On average, over the past 5 years, insiders at Neurogene Inc. have bought $2.72M and sold $76,247 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Samsara BioCapital GP, LLC (10 percent owner) — $1.26M. McMinn Rachel (Chief Executive Officer) — $969,000. Cvijic Christine Mikail (President and CFO) — $491,400.
The last purchase of 48,770 shares for transaction amount of $1.26M was made by Samsara BioCapital GP, LLC (10 percent owner) on 2024‑11‑26.
List of Insider Buy and Sell Transactions, Neurogene Inc.
| 2025-03-13 | Sale | Cvijic Christine Mikail | President and CFO | 4,501 0.0216% | $16.94 | $76,247 | -0.89% | |
| 2024-11-26 | Samsara BioCapital GP, LLC | 10 percent owner | 48,770 0.3334% | $25.83 | $1.26M | -31.22% | ||
| 2024-11-22 | McMinn Rachel | Chief Executive Officer | 47,500 0.2565% | $20.40 | $969,000 | -8.24% | ||
| 2024-11-22 | Cvijic Christine Mikail | President and CFO | 24,000 0.1301% | $20.48 | $491,400 | -8.24% |
NGNE Institutional Investors: Active Positions
| Increased Positions | 58 | +60.42% | 5M | +37.37% |
| Decreased Positions | 42 | -43.75% | 3M | -20.97% |
| New Positions | 28 | New | 946,654 | New |
| Sold Out Positions | 25 | Sold Out | 2M | Sold Out |
| Total Postitions | 112 | +16.67% | 16M | +16.4% |
NGNE Ownership Change vs Market
Institutional Investor Ownership
| Samsara Biocapital, Llc | $28,676.00 | 8.18% | 1.72M | +449,337 | +35.44% | 2024-12-31 |
| Blackrock, Inc. | $25,320.00 | 7.22% | 1.52M | +144,278 | +10.52% | 2024-12-31 |
| Rtw Investments, Lp | $22,549.00 | 6.43% | 1.35M | +215,000 | +18.94% | 2024-12-31 |
| Redmile Group, Llc | $22,040.00 | 6.29% | 1.32M | +355,416 | +36.86% | 2024-12-31 |
| Casdin Capital, Llc | $21,633.00 | 6.17% | 1.3M | +770,745 | +146.92% | 2024-12-31 |
| Ecor1 Capital, Llc | $21,231.00 | 6.05% | 1.27M | 0 | 0% | 2024-12-31 |
| Fmr Llc | $14,368.00 | 4.1% | 860,333 | +128,532 | +17.56% | 2024-12-31 |
| Commodore Capital Lp | $13,360.00 | 3.81% | 800,000 | +600,000 | +300% | 2024-12-31 |
| Baker Bros. Advisors Lp | $11,263.00 | 3.21% | 674,450 | +218,435 | +47.9% | 2024-12-31 |
| Vanguard Group Inc | $9,486.00 | 2.71% | 568,016 | -8,144 | -1.41% | 2024-12-31 |